Alberta Investment Management Corp (AIMCo)’s Abiomed Inc ABMD Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,800	Closed	-$1.26M	–	1378
2022 Q1	$1.26M	Hold	3,800	–	–	0.01%	903
2021 Q4	$1.36M	Hold	3,800	–	–	0.01%	678
2021 Q3	$1.24M	Hold	3,800	–	–	0.01%	738
2021 Q2	$1.19M	Buy	+3,800	New	+$1.17M	0.01%	751
2021 Q1	–	Sell	-44,367	Closed	-$14.4M	–	948
2020 Q4	$14.4M	Sell	44,367 -6,513	-13%	-$1.8M	0.13%	183
2020 Q3	$14.1M	Hold	50,880	–	–	0.15%	159
2020 Q2	$12.3M	Buy	50,880 +8,217	+19%	+$1.65M	0.15%	167
2020 Q1	$6.19M	Buy	42,663 +7,856	+23%	+$1.3M	0.11%	224
2019 Q4	$5.94M	Buy	34,807 +10,007	+40%	+$1.86M	0.05%	315
2019 Q3	$4.41M	Hold	24,800	–	–	0.04%	364
2019 Q2	$6.46M	Buy	24,800 +11,500	+86%	+$3.05M	0.06%	291
2019 Q1	$3.8M	Buy	13,300 +2,300	+21%	+$764K	0.04%	379
2018 Q4	$3.58M	Sell	11,000 -1,200	-10%	-$417K	0.04%	335
2018 Q3	$5.49M	Buy	+12,200	New	+$4.81M	0.05%	327

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s ABMD Position: Q2 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 3,800 shares — an estimated $1.26M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ABMD in Q3 2018 and held it in 14 quarters. The position peaked at $14.4M in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

Alberta Investment Management Corp (AIMCo) reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 3,800 Abiomed Inc shares in Q2 2022, an estimated $1.26M.
Alberta Investment Management Corp (AIMCo) first reported a position in Abiomed Inc in Q3 2018 and held it in 14 quarters.
Alberta Investment Management Corp (AIMCo)'s Abiomed Inc position peaked at $14.4M in Q4 2020.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2022, filed 15 Aug 2022.